Your browser doesn't support javascript.
loading
Association of HLA-A∗11:01, HLA-B∗39:01, and HLA-B∗56:03 with salazosulfapyridine-induced cutaneous adverse drug reactions.
Fukunaga, Koya; Tsukagoshi, Eri; Nakamura, Ryosuke; Matsunaga, Kayoko; Ozeki, Takeshi; Watanabe, Hideaki; Hasegawa, Akito; Hama, Natsumi; Kurata, Maiko; Mizukawa, Yoshiko; Watanabe, Yuko; Yamaguchi, Yukie; Niihara, Hiroyuki; Morita, Eishin; Asada, Hideo; Abe, Riichiro; Saito, Yoshiro; Mushiroda, Taisei.
Afiliação
  • Fukunaga K; Laboratory for Pharmacogenomics, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan; Division of Medicinal Safety Science, National Institute of Health Sciences, Kawasaki, Japan.
  • Tsukagoshi E; Division of Medicinal Safety Science, National Institute of Health Sciences, Kawasaki, Japan.
  • Nakamura R; Division of Medicinal Safety Science, National Institute of Health Sciences, Kawasaki, Japan.
  • Matsunaga K; Department of Integrative Medical Science for Allergic Disease, Fujita Health University School of Medicine, Nagoya, Japan.
  • Ozeki T; Laboratory for Pharmacogenomics, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.
  • Watanabe H; Department of Dermatology, Showa University Northern Yokohama Hospital, Yokohama, Japan.
  • Hasegawa A; Division of Dermatology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
  • Hama N; Division of Dermatology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
  • Kurata M; Department of Dermatology, Kyorin University School of Medicine, Tokyo, Japan.
  • Mizukawa Y; Department of Dermatology, Kyorin University School of Medicine, Tokyo, Japan.
  • Watanabe Y; Department of Environmental Immuno-Dermatology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
  • Yamaguchi Y; Department of Environmental Immuno-Dermatology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
  • Niihara H; Department of Dermatology, Faculty of Medicine, Shimane University, Shimane, Japan.
  • Morita E; Department of Dermatology, Faculty of Medicine, Shimane University, Shimane, Japan.
  • Asada H; Department of Dermatology, School of Medicine, Nara Medical University, Kashihara, Japan.
  • Abe R; Division of Dermatology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
  • Saito Y; Division of Medicinal Safety Science, National Institute of Health Sciences, Kawasaki, Japan.
  • Mushiroda T; Laboratory for Pharmacogenomics, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan. Electronic address: mushiroda@riken.jp.
J Allergy Clin Immunol Pract ; 12(5): 1355-1358.e3, 2024 May.
Article em En | MEDLINE | ID: mdl-38613561
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Antígenos HLA-A / Antígenos HLA-B Limite: Humans Idioma: En Revista: J Allergy Clin Immunol Pract Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Japão
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Antígenos HLA-A / Antígenos HLA-B Limite: Humans Idioma: En Revista: J Allergy Clin Immunol Pract Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Japão